Rize Oncology
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
301-1665 Ellis St, Kelowna, British Colu...Phone Number
(514) 796-2640Website
www.rizeoncology.comRevenue
<$5 MillionStock Symbol
GTTXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rize Oncology
At Rize Oncology, the company is developing STS-201 for the treatment of soft tissue sarcoma. Soft tissue sarcomas are a rare, diverse and often rapidly fatal group of tumors.Explore more
Rize Oncology Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rize Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Rize Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Rize Oncology has new funding data
Product Launch: Get notified when Rize Oncology launches new products
Earning: See what the market has to say on Rize Oncology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Rize Oncology
Click to see if Rize Oncology had a recent Job posting/layoffs
Check if Rize Oncology has recently received funding, and reach out quickly before it becomes old news!
Check out if Rize Oncology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Rize Oncology
Find more new buyers
Company Profile Activity
Activity Insights
Rize Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Rize Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rize Oncology.
Rize Oncology financials insights
Gather financial insights about Rize Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Stock Offering
$3.6M
2025
Share Placement
$500K
Rize Oncology Tech Stack
A closer look at the technologies used by Rize Oncology
Rize Oncology News & Media
CSE Bulletin: New Listing - GeneTether Therapeutics Inc. (GTTX)
Toronto, Ontario--(Newsfile Corp. - Le 28 mars/March 2022) - The common shares of GeneTether Therapeutics Inc., have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. GeneTether Therapeutics is an innovative genetic medicines company focused on...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Rize Oncology
Sign Up For FreeTo access detailed company insights
At Rize Oncology, the company is developing STS-201 for the treatment of soft tissue sarcoma. Soft tissue sarcomas are a rare, diverse and often rapidly fatal group of tumors.... Read More
